News Releases

September 25, 2018
Neon Therapeutics to Present at Upcoming Investor Conferences in October
CAMBRIDGE, Mass. , Sept. 25, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today announced that Hugh O’Dowd, President and Chief Executive Officer of Neon, will present at the following upcoming
Additional Formats
Displaying 1 - 10 of 16